The first stop for professional medicines advice

Ropinirole

Published
Topics: Mental health and illnessNeurological disordersPatent expiries · RopiniroleSafety in BreastfeedingStability in dosette boxes ·
Contents
  1. dm+d
  2. Articles
  3. Medicine Compliance Aid Stability
    1. Requip · GlaxoSmithKline UK
    2. Requip XL · GlaxoSmithKline UK
    3. Adartrel · GlaxoSmithKline UK
    4. generic · Mylan
    5. Raponer XL · Accord-UK Ltd
  4. Lactation Safety Information

dm+d

108473005

Articles

Managing specific interactions with smoking

31 October 2023

Parkinson’s disease medicines in swallowing difficulties

13 June 2022Guidance to help you ensure your patients with Parkinson’s Disease are able to get the most from their medicines if they develop swallowing difficulties
Search Articles

Medicine Compliance Aid Stability

RequipGlaxoSmithKline UK

GlaxoSmithKline UK
Requip
Tablets f/c 0.25mg, 0.5mg, 1mg, 2mg, 5mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from moisture and light.
25 October 2022
Usage of Medicines in Compliance Aids

Requip XLGlaxoSmithKline UK

GlaxoSmithKline UK
Requip XL
Tablets m/r f/c 2mg, 4mg, 8mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special precautions for storage.
7 November 2022
Usage of Medicines in Compliance Aids

AdartrelGlaxoSmithKline UK

GlaxoSmithKline UK
Adartrel
Tablets f/c 250 micrograms, 500 microgram, 2mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from light. Store in original package
16 November 2022
Usage of Medicines in Compliance Aids

genericMylan

Mylan
generic
Tablets f/c 250 micrograms, 500 microgram, 1mg, 2mg, 5mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special requirements for storage
7 November 2022
Usage of Medicines in Compliance Aids

Raponer XLAccord-UK Ltd

Accord-UK Ltd
Raponer XL
Tablets m/r 2mg, 4mg, 8mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special requirements for storage.
7 November 2022
Usage of Medicines in Compliance Aids

Lactation Safety Information

No
Levodopa, (as co-beneldopa or co-careldopa)
May interfere with lactation
No published evidence of safety
Dopamine receptor agonist
Safety in Lactation: Dopaminergic drugs used in Parkinsons disease
25 June 2021